SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

AstraZeneca Reconfirms FY 2026 Revenue and Core EPS Guidance

AstraZeneca reconfirmed its total revenue and core EPS guidance for FY 2026.

Related stories